ArticleTranslational lung cancer research2023

Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?

Shruti R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.